-
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy.
Nature. 2004 Jun 10;429(6992):629-35
PMID: 15190345
-
Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes.
Biomaterials. 2004 Nov;25(26):5681-703
PMID: 15147815
-
The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes.
Biochim Biophys Acta. 1981 May 18;674(3):354-71
PMID: 6165399
-
Regulation of extravascular coagulation by microvascular permeability.
Science. 1985 Mar 1;227(4690):1059-61
PMID: 3975602
-
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
AJR Am J Roentgenol. 1989 Jan;152(1):167-73
PMID: 2783272
-
Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.
Cancer Res. 1990 Aug 1;50(15):4478-84
PMID: 2369726
-
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.
J Immunol Methods. 1994 Sep 14;174(1-2):83-93
PMID: 8083541
-
Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.
Genes Dev. 1995 Aug 15;9(16):2020-33
PMID: 7649481
-
Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
Magn Reson Imaging. 1995;13(5):661-74
PMID: 8569441
-
Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
Magn Reson Imaging. 1995;13(5):675-91
PMID: 8569442
-
Organ targeting in vivo using phage display peptide libraries.
Nature. 1996 Mar 28;380(6572):364-6
PMID: 8598934
-
Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice.
J Biomed Mater Res. 1996 Jul;31(3):401-8
PMID: 8806067
-
Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature.
Science. 1997 Jan 24;275(5299):547-50
PMID: 8999802
-
Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages.
J Magn Reson Imaging. 1997 Nov-Dec;7(6):1140-5
PMID: 9400860
-
Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor.
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8663-8
PMID: 10411932
-
Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.
Biomed Microdevices. 2004 Dec;6(4):297-309
PMID: 15548877
-
Platelet depletion by anti-CD41 (alphaIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines.
Blood. 2005 Mar 1;105(5):1956-63
PMID: 15494426
-
The MET oncogene drives a genetic programme linking cancer to haemostasis.
Nature. 2005 Mar 17;434(7031):396-400
PMID: 15772665
-
Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy.
Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7087s-7092s
PMID: 16203807
-
A selective tumor microvasculature thrombogen that targets a novel receptor complex in the tumor angiogenic microenvironment.
Cancer Res. 2005 Dec 1;65(23):11109-17
PMID: 16322261
-
Nanoparticle-induced platelet aggregation and vascular thrombosis.
Br J Pharmacol. 2005 Nov;146(6):882-93
PMID: 16158070
-
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.
Clin Cancer Res. 2006 Feb 15;12(4):1317-24
PMID: 16489089
-
Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.
Nano Lett. 2006 Apr;6(4):669-76
PMID: 16608262
-
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds.
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2800-4
PMID: 16476999
-
Transgenic mouse models of human breast cancer.
Oncogene. 2000 Dec 11;19(53):6130-7
PMID: 11156526
-
Long-circulating and target-specific nanoparticles: theory to practice.
Pharmacol Rev. 2001 Jun;53(2):283-318
PMID: 11356986
-
A tumor-homing peptide with a targeting specificity related to lymphatic vessels.
Nat Med. 2002 Jul;8(7):751-5
PMID: 12053175
-
Nanocrystal targeting in vivo.
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12617-21
PMID: 12235356
-
Specialization of tumour vasculature.
Nat Rev Cancer. 2002 Feb;2(2):83-90
PMID: 12635171
-
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma.
Cancer Cell. 2003 Nov;4(5):383-91
PMID: 14667505
-
Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo.
Circulation. 2004 Mar 16;109(10):1320-5
PMID: 15007013
-
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.
Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9381-6
PMID: 15197262